Kurt A. Gustafson

2011 - Halozyme Therapeutics

In 2011, Kurt A. Gustafson earned a total compensation of $754.4K as Former Vice President and Chief Financial Officer at Halozyme Therapeutics, a 54% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$95,000
Option Awards$170,788
Salary$320,850
Stock Awards$160,080
Other$7,675
Total$754,393

Gustafson received $320.9K in salary, accounting for 43% of the total pay in 2011.

Gustafson also received $95K in non-equity incentive plan, $170.8K in option awards, $160.1K in stock awards and $7.7K in other compensation.

Rankings

In 2011, Kurt A. Gustafson's compensation ranked 6,667th out of 10,747 executives tracked by ExecPay. In other words, Gustafson earned more than 38.0% of executives.

ClassificationRankingPercentile
All
6,667
out of 10,747
38th
Division
Manufacturing
2,418
out of 3,960
39th
Major group
Chemicals And Allied Products
572
out of 1,033
45th
Industry group
Drugs
377
out of 781
52nd
Industry
Biological Products, Except Diagnostic Substances
58
out of 157
63rd
Source: SEC filing on April 7, 2014.

Gustafson's colleagues

We found six more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2011.

2011

James Shaffer

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2011

Jean Liu

Halozyme Therapeutics

General Counsel

2011

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2011

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2011

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2011

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

News

You may also like